TELA Bio (TELA) Restructuring Costs (2024 - 2026)

TELA Bio's Restructuring Costs history runs 3 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• On a quarterly basis, Restructuring Costs rose 13.47% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $8.5 million, a 16.34% increase from a year earlier, with the FY2025 full-year figure at $8.2 million, up 14.05% from the prior year.
• Restructuring Costs rose to $2.1 million in Q1 2026 per TELA's latest filing, from $2.1 million in the prior quarter.
• Across five years, Restructuring Costs topped out at $2.2 million in Q2 2025 and bottomed at $1.8 million in Q2 2024.
• The 3-year median for Restructuring Costs is $1.9 million (2025), against an average of $2.0 million.
• Biggest YoY gain for Restructuring Costs was 21.24% in 2025; the steepest drop was 4.26% in 2025.
• Year by year, Restructuring Costs stood at $1.8 million in 2024, then advanced by 13.69% to $2.1 million in 2025, then gained by 2.64% to $2.1 million in 2026.
• Per Business Quant, the three latest TELA Restructuring Costs figures stand at $2.1 million (Q1 2026), $2.1 million (Q4 2025), and $2.1 million (Q3 2025).